Clinical Trial Update: A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 open-label, two-arm, single-sequence crossover study in healthy adult volunteers to evaluate pharmacokinetic interaction and safety between two invest…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• UIC202502
• UIC202505

Snippet

Sponsor: Korea United Pharm. Inc. | Conditions: Dyslipidemia | Phase 1 | Status: RECRUITING